Skip to main content
Skip to search
Skip to main menu
Skip to page specific menu
Skip to footer area
Site Menu
Close
Search the Ali Lab site
Search
A-Z
|
Search All UMass Chan Sites
Research
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
APOBEC3 Inhibitors
NMR Facility
Publications
The Lab
The Lab
The PI
Lab Members
Contact
Additional Resources
About
Admissions
Education
Faculty
Research
Diversity
Giving
Search
Close Search
Ali Lab
Page Menu
x
Ali Lab
Home
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
APOBEC3 Inhibitors
NMR Facility
Publications
The Lab
The PI
Lab Members
Contact
Ali Lab
Home
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
APOBEC3 Inhibitors
NMR Facility
Publications
The Lab
The PI
Lab Members
Contact
Our most recent publications:
Total:
displaying 10 out of
17
results
Inhibiting HTLV-1 Protease: A Viable Antiviral Target
Tuesday, February 23, 2021
Author(s):
Gordon J Lockbaum,Mina Henes,Nathaniel Talledge,Linah N Rusere,Klajdi Kosovrasti,Ellen A Nalivaika,Mohan Somasundaran,Akbar Ali,Louis M Mansky,Nese Kurt Yilmaz,Celia A Schiffer
Source:
ACS chemical biology
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
Thursday, January 28, 2021
Author(s):
Gordon J Lockbaum,Archie C Reyes,Jeong Min Lee,Ronak Tilvawala,Ellen A Nalivaika,Akbar Ali,Nese Kurt Yilmaz,Paul R Thompson,Celia A Schiffer
Source:
Viruses
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond
Thursday, January 07, 2021
Author(s):
Ashley N Matthew,Florian Leidner,Gordon J Lockbaum,Mina Henes,Jacqueto Zephyr,Shurong Hou,Desaboini Nageswara Rao,Jennifer Timm,Linah N Rusere,Debra A Ragland,Janet L Paulsen,Kristina Prachanronarong,Djade I Soumana,Ellen A Nalivaika,Nese Kurt Yilmaz,Akbar Ali,Celia A Schiffer
Source:
Chemical reviews
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease
Tuesday, August 28, 2018
Author(s):
Ashley N Matthew,Florian Leidner,Alicia Newton,Christos J Petropoulos,Wei Huang,Akbar Ali,Nese KurtYilmaz,Celia A Schiffer
Source:
Structure (London, England : 1993)
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants
Tuesday, July 24, 2018
Author(s):
Linah N Rusere,Ashley N Matthew,Gordon J Lockbaum,Muhammad Jahangir,Alicia Newton,Christos J Petropoulos,Wei Huang,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
ACS medicinal chemistry letters
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants
Friday, June 09, 2017
Author(s):
Ashley N Matthew,Jacqueto Zephyr,Caitlin J Hill,Muhammad Jahangir,Alicia Newton,Christos J Petropoulos,Wei Huang,Nese Kurt-Yilmaz,Celia A Schiffer,Akbar Ali
Source:
Journal of medicinal chemistry
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side
Friday, March 17, 2017
Author(s):
Kuan-Hung Lin,Akbar Ali,Linah Rusere,Djade I Soumana,Nese Kurt Yilmaz,Celia A Schiffer
Source:
Journal of virology
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease
Friday, August 12, 2016
Author(s):
Djadé I Soumana,Nese Kurt Yilmaz,Akbar Ali,Kristina L Prachanronarong,Celia A Schiffer
Source:
Journal of the American Chemical Society
P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates
Wednesday, January 06, 2016
Author(s):
Miriam Sansó,Rebecca S Levin,Jesse J Lipp,Vivien Ya-Fan Wang,Ann Katrin Greifenberg,Elizabeth M Quezada,Akbar Ali,Animesh Ghosh,Stéphane Larochelle,Tariq M Rana,Matthias Geyer,Liang Tong,Kevan M Shokat,Robert P Fisher
Source:
Genes & development
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172
Sunday, December 20, 2015
Author(s):
Djadé I Soumana,Nese Kurt Yilmaz,Kristina L Prachanronarong,Cihan Aydin,Akbar Ali,Celia A Schiffer
Source:
ACS chemical biology
Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy
Tuesday, May 12, 2015
Author(s):
Jean Ndjomou,M Josie Corby,Noreena L Sweeney,Alicia M Hanson,Cihan Aydin,Akbar Ali,Celia A Schiffer,Kelin Li,Kevin J Frankowski,Frank J Schoenen,David N Frick
Source:
ACS chemical biology
Structural analysis of asunaprevir resistance in HCV NS3/4A protease
Tuesday, September 23, 2014
Author(s):
Djadé I Soumana,Akbar Ali,Celia A Schiffer
Source:
ACS chemical biology
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance
Tuesday, September 10, 2013
Author(s):
Madhavi N L Nalam,Akbar Ali,G S Kiran Kumar Reddy,Hong Cao,Saima G Anjum,Michael D Altman,Nese Kurt Yilmaz,Bruce Tidor,Tariq M Rana,Celia A Schiffer
Source:
Chemistry & biology
Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis
Friday, August 02, 2013
Author(s):
Ahmed Fazly,Charu Jain,Amie C Dehner,Luca Issi,Elizabeth A Lilly,Akbar Ali,Hong Cao,Paul L Fidel,Reeta P Rao,Paul D Kaufman
Source:
Proceedings of the National Academy of Sciences of the United States of America
Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance
Friday, April 19, 2013
Author(s):
Akbar Ali,Cihan Aydin,Reinhold Gildemeister,Keith P Romano,Hong Cao,Ayşegül Ozen,Djade Soumana,Alicia Newton,Christos J Petropoulos,Wei Huang,Celia A Schiffer
Source:
ACS chemical biology
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Friday, November 19, 2010
Author(s):
Keith P Romano,Akbar Ali,William E Royer,Celia A Schiffer
Source:
Proceedings of the National Academy of Sciences of the United States of America
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones
Thursday, October 21, 2010
Author(s):
Akbar Ali,G S Kiran Kumar Reddy,Madhavi N L Nalam,Saima Ghafoor Anjum,Hong Cao,Celia A Schiffer,Tariq M Rana
Source:
Journal of medicinal chemistry
Back To Top ▲
